Non-ablative fractional photothermolysis resurfaces skin surface by punching micro-columns of laser beam energy in a fractional manner rather than a solid laser beam.Thulium targets water content in the epidermis, and is therefore fit to treat all skin types since it does not target melanin.Thulium:glass laser is FDA approved for treating melasma, post-inflammatory hyperpigmentation, age spots, solar lentigines, actinic keratosia and vascular dyschromias.Patients require only topical anesthesia with less clinical and social downtime, less painful with less discomfort during treatment sessions.